II.2.2) Additional CPV code(s)
73000000
73100000
73110000
73111000
73120000
73300000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
Located within one of the following three NHS Scotland Innovation Hubs: North of Scotland Test Bed, West of Scotland Innovation Hub, Health Innovation South East Scotland.
II.2.4) Description of the procurement
Contracts will be between NHS Golden Jubilee and winning participants. Phase 1 is allocated 60,000 GPB inclusive of VAT for a maximum of 4 projects. Phase 1 projects can range in size up to a total cost of 15,000 GPB inclusive of VAT.
The open innovation challenge provides an opportunity for organisations, working in partnership with NHS Scotland Innovation Hubs to develop disruptive innovative solutions that focus on the monitoring of jaundiced newborns at home. These solutions will focus on near-patient bilirubin testing to develop innovative care pathways and enable family centred care at home for babies who do not require to be in hospital.
Innovative solutions are sought for near-patient bilirubin monitoring of newborns which are accurate, efficient, safe, accessible and equitable. These solutions will enable the development of innovative care pathways.
Solutions must be working towards compliance with UKAS accredited point of care testing (POCT) (ISO15189:2022) methodology for analysis.
When fully developed, solutions must include a real-time process to incorporate results into NHS Scotland electronic patient records.
Phase 1: Technical feasibility studies
This means planned research or critical investigation to gain new knowledge and skills for developing new products, processes or services.
There is a potential Phase 2 planned with the expectation that 2 contracts are awarded, chosen from the successful phase 1 applicants, to develop a prototype and undertake field testing for up to 12 months. The total budget for phase 2 is 160,000 GPB. Phase 2 projects can range in size up to total costs of 80,000 GPB inclusive of VAT. At this stage contracts will be given for phase 1 only.
SHIP reserves the right not to award any contracts. SHIP are not committed to proceeding to Phase 2 whether or not the previous phases were successful.
SHIP gives no guarantee or warranty as to the nature, or number of projects funded.
To lead a project, you can:
- be any type of organisation of any size, registered in the UK, European Union (EU) and the European Economic Area (EEA) that can demonstrate a credible and practical route to market
- work alone or with others from business, research organisations, research and technology organisations or the third sector as subcontractors.
Contracts will be given to successful applicants. Contract terms and conditions are accessible as an additional document to this notice; "SBRI_ Authority Contract V7 Scotland - CLO 2 - FINAL"
Under current restrictions, this competition will not fund any procurement, commercial, business development or supply chain activity with any Russian and Belarusian entity as lead, partner or subcontractor. This includes any goods or services originating from a Russian and Belarusian source.
Briefing Event
25th October 2023 10:00-12:00 UK Time.
Event registration: https://book.shsc.scot/shsc/frontend/reg/thome.csp?pageID=206690&eventID=560&traceRedir=2
Any adoption and implementation of a solution from this competition would be the subject of a separate, possibly competitive, procurement exercise. This competition covers R&D not the purchase of any solution.
Please do not contact the NHS Scotland Innovation Hubs direct. If you have any questions relating to NHS Scotland Innovation Hubs available resources, please direct your question to the Q&A portal on PCS before 11am UK time on 6th December 2023 or at the Q&A session during the Briefing Event on 25th October 2023 10:00 – 12:00 UK time.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents.
The total funding available for the competition can change. The funders have the right to:
- adjust the provisional funding allocations between the phases
- apply a ‘portfolio’ approach
- The Contractor shall effect and maintain with a reputable insurance company a policy or policies of insurance providing an adequate level of cover in respect of all risks which may be incurred by the Contractor, arising out of the Contractor's performance of the Agreement.
The Contractor shall hold employer's liability insurance in respect of staff in accordance with any legal requirement for the time being in force.
Contracts will be awarded to a single legal entity only. However, if you can justify subcontracting components of the work, you can engage specialists or advisers. This work will still be the responsibility of the main contractor.
Applications must have at least 50% of the contract value attributed directly and exclusively for R&D Services. R&D does not include:
- commercial development activities such as quantity production
- supply to establish commercial viability or to recover R&D costs
- integration, customisation, incremental adaptations and improvements to existing products or processes.
Bidders must demonstrate, in the application form and through any requested additional documentation, how they will meet each requirement set out in the documents accessible through this notice and how any deviations will be remedied. Note, it is not sufficient to simply state adherence, bidders must provide sufficient evidence to allow the bid assessment team to be satisfied each requirement will be met.
II.2.6) Estimated value
Value excluding VAT:
50 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 4
This contract is subject to renewal: No
II.2.10) Information about variants
Variants will be accepted:
Yes
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No